Johnson & Johnson and its subsidiaries helped fuel the state's opioid crisis, according to an Oklahoma judge, who ordered the company to pay $572 million. The ruling followed the first state
opioid case to make it to trial and could help shape negotiations over roughly 1,500 similar lawsuits filed by state, local and tribal governments. Oklahoma reached settlements with two other
defendant groups — a $270 million deal with OxyContin-maker Purdue Pharma and an $85 million settlement with Israeli-owned Teva Pharmaceutical Industries Ltd.
Read the whole story at Chicago Tribune »
